Clinical and genomic correlates of imatinib response in melanomas with KIT alterations. Jung S, Armstrong E, Wei AZ, Ye F, et al. Br J Cancer 2022 Aug 23. pii: 10.1038/s41416-022-01942.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Jung S, Armstrong E, Wei AZ, Ye F, et al. Clinical and genomic correlates of imatinib response in melanomas with KIT alterations. Br J Cancer 2022 Aug 23. pii: 10.1038/s41416-022-01942.
PMID: 35999272